Bibliography
- Zink D , FischerAH, NickersonJA: Nuclear structure in cancer cells.Nat. Rev. Cancer4 , 677–687 (2004).
- DeMay RM : The Art and Science of Cytopathology. American Society of Clinical Pathologists Press, Chicago, USA (1996).
- Mulder JW , OfferhausGJ, de Feyter EP et al.: The relationship of quantitative nuclear morphology to molecular genetic alterations in the adenoma-carcinoma sequence of the large bowel. Am. J. Pathol.141 , 797–804 (1992).
- Pienta KJ , PartinAW, CoffeyDS: Cancer as a disease of DNA organization and dynamic cell structure.Cancer Res.49 , 2525–2532 (1989).
- Boone CW , SanfordKK, FrostJK, MantelN, GillGW, JonesGM: Cytomorphologic evaluation of the neoplastic potential of 28 cell culture lines by a panel of diagnostic cytopathologists.Int. J. Cancer38 , 361–367 (1986).
- Goldman RD , GruenbaumY, MoirRD, ShumakerDK, SpannTP: Nuclear lamins: building blocks of nuclear architecture.Genes Dev.16 , 533–547 (2002).
- Ben-Ze‘ev A : Virus replication in infected epithelial cells is coupled to cell shape-responsive metabolic controls.J. Cell Physiol.114 , 145–152 (1983).
- Benecke BJ , Ben-Ze‘evA, PenmanS: The control of mRNA production, translation and turnover in suspended and reattached anchorage-dependent fibroblasts.Cell14 , 931–939 (1978).
- Ben-Ze‘ev A , FarmerSR, PenmanS: Protein synthesis requires cell-surface contact while nuclear events respond to cell shape in anchorage-dependent fibroblasts.Cell21 , 365–372 (1980).
- Folkman J , MosconaA: Role of cell shape in growth control.Nature273 , 345–349 (1978).
- Wittelsberger SC , KleeneK, PenmanS: Progressive loss of shape-responsive metabolic controls in cells with increasingly transformed phenotype.Cell24 , 859–866 (1981).
- Zastrow MS , VlcekS, WilsonKL: Proteins that bind A-type lamins: integrating isolated clues.J. Cell Sci.117 , 979–987 (2004).
- Vogelstein B , PardollDM, CoffeyDS: Supercoiled loops and eucaryotic DNA replicaton.Cell22 , 79–85 (1980).
- Alvarez JD , YasuiDH, NiidaHet al.: The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development.Genes Dev.14 , 521–535 (2000).
- Bolzer A , KrethG, SoloveiIet al.: Three-dimensional maps of all chromosomes in human male fibroblast nuclei and prometaphase rosettes.PLoS Biol.3 , e157 (2005).
- Cremer M , KupperK, WaglerBet al.: Inheritance of gene density-related higher order chromatin arrangements in normal and tumor cell nuclei.J. Cell Biol.162 , 809–820 (2003).
- Roix JJ , McQueenPG, MunsonPJ, ParadaLA, MisteliT: Spatial proximity of translocation-prone gene loci in human lymphomas.Nat. Genet.34 , 287–291 (2003).
- Colicelli J : Human RAS superfamily proteins and related GTPases.Sci. STKE250 , RE13 (2004).
- Fischer AH , ChadeeDN, WrightJA, GanslerTS, DavieJR: Ras-associated nuclear structural change appears functionally significant and independent of the mitotic signaling pathway.J. Cell Biochem.70 , 130–140 (1998).
- Pratilas CA , SolitDB: Targeting the mitogen-activated protein kinase pathway: physiological feedback and drug response.Clin. Cancer Res.16 , 3329–3334 (2010).
- Wolffe A : Chromatin. Academic Press, New York, NY, USA (1998).
- Laitinen J , SistonenL, AlitaloK, HolttaE: c-Ha-rasVal 12 oncogene-transformed NIH-3T3 fibroblasts display more decondensed nucleosomal organization than normal fibroblasts.J. Cell Biol.111 , 9–17 (1990).
- Wells SA Jr, Santoro M: Targeting the RET pathway in thyroid cancer. Clin. Cancer Res.15 , 7119–7123 (2009).
- Frost JK : The cell in health and disease. An evaluation of cellular morphologic expression of biologic behavior. 2nd, revised edition.Monogr. Clin. Cytol.2 , 1–304 (1986).
- Ellis L , AtadjaPW, JohnstoneRW: Epigenetics in cancer: targeting chromatin modifications.Mol. Cancer Ther.8 , 1409–20 (2009).
- Clapier CR , CairnsBR: The biology of chromatin remodeling complexes.Annu. Rev. Biochem.78 , 273–304 (2009).
- Luger K , MaderAW, RichmondRK, SargentDF, RichmondTJ: Crystal structure of the nucleosome core particle at 2.8 A resolution.Nature389 , 251–260 (1997).
- Fraga MF , BallestarE, Villar-GareaAet al.: Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer.Nat. Genet.37 , 391–400 (2005).
- Seligson DB , HorvathS, ShiTet al.: Global histone modification patterns predict risk of prostate cancer recurrence.Nature435 , 1262–1266 (2005).
- Ehrenhofer-Murray AE : Chromatin dynamics at DNA replication, transcription and repair.Eur. J. Biochem.271 , 2335–2349 (2004).
- Puig OM , BellesE, Lopez-RodasG, SendraR, TorderaV: Interaction between N-terminal domain of H4 and DNA is regulated by the acetylation degree.Biochim. Biophys. Acta1397 , 79–90 (1998).
- Elsheikh SE , GreenAR, RakhaEAet al.: Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.Cancer Res.69 , 3802–3809 (2009).
- Shogren-Knaak M , IshiiH, SunJM, PazinMJ, DavieJR, PetersonCL: Histone H4-K16 acetylation controls chromatin structure and protein interactions.Science311 , 844–847 (2006).
- Shogren-Knaak M , PetersonCL: Switching on chromatin: mechanistic role of histone H4-K16 acetylation.Cell Cycle5 , 1361–1365 (2006).
- Miller KM , TjeertesJV, CoatesJet al.: Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining.Nat. Struct. Mol. Biol.17 , 1144–1151 (2010).
- Vaquero A , ScherM, LeeD, Erdjument-BromageH, TempstP, ReinbergD: Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin.Mol. Cell16 , 93–105 (2004).
- Yang H , MizzenCA: The multiple facets of histone H4-lysine 20 methylation.Biochem Cell Biol.87 , 151–161 (2009).
- Nishioka K , RiceJC, SarmaKet al.: PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin.Mol. Cell9 , 1201–1213 (2002).
- Schotta G , LachnerM, SarmaKet al.: A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev.18 , 1251–1262 (2004).
- Bannister AJ , KouzaridesT: Reversing histone methylation.Nature436 , 1103–1106 (2005).
- Kirschmann DA , LiningerRA, GardnerLMet al.: Down-regulation of HP1Hsα expression is associated with the metastatic phenotype in breast cancer.Cancer Res.60 , 3359–3363 (2000).
- Schmiedeberg L , WeisshartK, DiekmannS, MeyerZ, HoersteG, HemmerichP: High- and low-mobility populations of HP1 in heterochromatin of mammalian cells.Mol. Biol. Cell15 , 2819–33 (2004).
- Capranico G , JaxelC, RobergeM, KohnKW, PommierY: Nucleosome positioning as a critical determinant for the DNA cleavage sites of mammalian DNA topoisomerase II in reconstituted simian virus 40 chromatin.Nucleic Acids Res.18 , 4553–4559 (1990).
- Kas E , PoljakL, AdachiY, LaemmliUK: A model for chromatin opening: stimulation of topoisomerase II and restriction enzyme cleavage of chromatin by distamycin.EMBO J.12 , 115–126 (1993).
- Poljak L , KasE: Resolving the role of topoisomerase II in chromatin structure and function.Trends Cell Biol.5 , 348–54 (1995).
- Reeves R , NissenMS: The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure.J. Biol. Chem.265 , 8573–8582 (1990).
- Coll M , FrederickCA, WangAH, RichA: A bifurcated hydrogen-bonded conformation in the d(A.T) base pairs of the DNA dodecamer d(CGCAAATTTGCG) and its complex with distamycin.Proc. Natl Acad. Sci. USA84 , 8385–8389 (1987).
- Kim MS , BlakeM, BaekJH, KohlhagenG, PommierY, CarrierF: Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA.Cancer Res.63 , 7291–7300 (2003).
- Schrump DS : Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications.Clin. Cancer Res.15 , 3947–3957 (2009).
- Ungerstedt JS , SowaY, XuWSet al.: Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors.Proc. Natl Acad. Sci. USA102 , 673–678 (2005).
- Butler LM , ZhouX, XuWSet al. The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc. Natl Acad. Sci. USA 99 , 11700–11705 (2002).
- Miura K , TauraK, KodamaY, SchnablB, BrennerDA: Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.Hepatology48 , 1420–1429 (2008).
- Zhu H , ShanL, SchillerPW, MaiA, PengT: Histone deacetylase-3 activation promotes tumor necrosis factor-α (TNF-α) expression in cardiomyocytes during lipopolysaccharide stimulation.J. Biol. Chem.285 , 9429–9436 (2010).
- Pluemsampant S , SafronovaOS, NakahamaK, MoritaI: Protein kinase CK2 is a key activator of histone deacetylase in hypoxia-associated tumors.Int. J. Cancer122 , 333–341 (2008).
- Kim MS , KwonHJ, LeeYMet al.: Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes.Nat. Med.7 , 437–443 (2001).
- Lee JH , ChoyML, NgoL, FosterSS, MarksPA: Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair.Proc. Natl Acad. Sci. USA107 , 14639–14644 (2010).
- Siegel D , HusseinM, BelaniCet al.: Vorinostat in solid and hematologic malignancies.J. Hematol. Oncol.2 , 31 (2009).
- Cang S , MaY, LiuD: New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer.J. Hematol. Oncol.2 , 22 (2009).
- Oshita F , YamadaK, NomuraI, NodaK: Gene-specific damage produced by topoisomerase inhibitors in human lung cancer cells and peripheral mononuclear cells as assayed by polymerase chain reaction-stop assay.AntiCancer Res.18 , 3389–3393 (1998).
- Bonner WM , RedonCE, DickeyJSet al.: ΓH2AX and cancer.Nat. Rev. Cancer8 , 957–967 (2008).
- Bailly C : Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs.Crit. Rev. Oncol. Hematol.45 , 91–108 (2003).
- D‘Arpa P , BeardmoreC, LiuLF: Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.Cancer Res.50 , 6919–6924 (1990).
- Razin SV , ChernokhvostovVV, RoodynAV, ZbarskyIB, GeorgievGP: Proteins tightly bound to DNA in the regions of DNA attachment to the skeletal structures of interphase nuclei and metaphase chromosomes.Cell27 , 65–73 (1981).
- Kim MS , BaekJH, ChakravartyDet al.: Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA).Exp. Cell Res.306 , 94–102 (2005).
- Thoma F : Light and dark in chromatin repair: repair of UV-induced DNA lesions by photolyase and nucleotide excision repair.EMBO J.18 , 6585–6598 (1999).
- Siddiqi S , MillsJ, MatushanskyI: Epigenetic remodeling of chromatin architecture: Exploring tumor differentiation therpies in mesenchymal stem cells and sarcomas.Curr. Stem Cell Res. Ther.5 , 63–73 (2010).
- Ishihara KTA , KanekoM, SugenoHet al.: Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.Life Sci.80 , 1213–1220 (2007).
- Bar-Ner M TA, Tsokos M, Magrath IT, Samid D: Phenylbutyrate induces cell differentiation and modulates Epstein–Barr virus gene expression in Burkitt‘s lymphoma cells. Clin. Cancer Res.5(6) , 1509–1516 (1999).
- Watanabe MCI , IshikuraY, NakagawaTet al.: Tumor cell growth inhibition and cell differentiation analysis in a canine mammary tumor cell line (MCM-B2) treated with four chemical reagents. J. Vet. Med. Sci.71 , 1413–1417 (2009).
- Politis PK AS, Hurel C, Papadodima O, Matsas R: BM88/Cend1 is involved in histone deacetylase inhibition-mediated growth arrest and differentiation of neuroblastoma cells. 582 , 741–748 (2008).
- Richly H , LangeM, SimboeckE, Di Croce L: Setting and resetting of epigenetic marks in malignant transformation and development. Bioessays32 , 669–679 (2010).
- Lister R , PelizzolaM, DowenRHet al.: Human DNA methylomes at base resolution show widespread epigenomic differences.Nature462 , 315–322 (2009).
- Munster P , Troso-SandovalT, RosenNet al.: The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.Cancer Res.61 , 8492–8497 (2001).